Who Qualifies for Tirzepatide for Weight Loss? 2026 Eligibility Checklist

Core eligibility criteria often used in practice

These are common regulatory and clinical anchors, but individual prescribing decisions are still clinician-specific and patient-specific.

• BMI 30 or greater, or
• BMI 27 or greater with at least one weight-related condition
• Commitment to reduced-calorie nutrition and activity changes alongside medication

Sources: [1] [2]

Common reasons a provider may pause or decline start

A pause is not always a permanent no. In many cases it is a risk-management step to improve safety before treatment decisions are finalized.

• Potential contraindication history requiring alternate planning
• Safety concerns that need additional evaluation first
• Medication interactions or risk profile concerns
• Lack of readiness for monitoring, follow-up, or adherence basics

Sources: [2] [3] [4]

What to bring to your consultation

The more concrete your context, the easier it is for a provider to decide whether tirzepatide is a safe and realistic fit.

• Current medications and supplement list
• Prior weight-management medication history
• Recent symptoms relevant to GI or metabolic health
• Budget and follow-up constraints
• Your top three concerns about safety and expectations

Sources: [2] [4]

Eligibility questions worth asking directly

• Do I meet your medical criteria today, and why?
• What safety factors matter most in my case?
• What would make you postpone start?
• How will we monitor response and tolerability?
• What is the alternative plan if tirzepatide is not appropriate?

Sources: [2] [3]

Bottom line

Eligibility is a clinical decision, not a marketing checkbox. A strong checklist improves clarity, but it does not replace provider judgment.

If criteria and safety language are vague, pause and ask for explicit answers before moving forward.

Sources: [1] [2] [5]